SCHEMBL6498658

SCHEMBL6498658

CC(NC(=O)C1CCN(C(=O)C=Cc2ccc(OCc3ccccc3)c(Cl)c2Cl)CC1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 4/20 0.47
ITGB2 P05107 3/20 0.47
ICAM1 P05362 3/20 0.47
CAPN1 P07384 4/20 0.45
APP P05067 5/20 0.44
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
APOBEC3A P31941 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498653 1.00 ITGAL (0.47) ITGALITGB2ICAM1CAPN1APP
SCHEMBL8298731 0.90 ITGAL (0.48) ITGALITGB2ICAM1CAPN1POLB
SCHEMBL6504520 0.90 ITGAL (0.48) ITGALITGB2ICAM1CAPN1POLB
SCHEMBL6504517 0.90 ITGAL (0.48) ITGALITGB2ICAM1CAPN1POLB
SCHEMBL6497470 0.88 ITGAL (0.45) ITGALITGB2ICAM1CAPN1SMN1; SMN2
SCHEMBL8298381 0.88 ITGAL (0.45) ITGALITGB2ICAM1CAPN1SMN1; SMN2
SCHEMBL6497465 0.88 ITGAL (0.45) ITGALITGB2ICAM1CAPN1SMN1; SMN2
SCHEMBL6504723 0.87 ITGAL (0.54) ITGALITGB2ICAM1CAPN1SMN1; SMN2
SCHEMBL6504728 0.87 ITGAL (0.54) ITGALITGB2ICAM1CAPN1SMN1; SMN2
SCHEMBL6499774 0.84 CAPN1 (0.45) ITGALITGB2ICAM1CAPN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed